EcoDrugPlus

Mapk Activated Protein Kinase 5

Ensembl ID : ENSKMAG00000000893
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSKMAG00000014182
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSKMAG00000000879
Gene Symbol: MDM2
3 Cross references
275 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSKMAG00000007045
Gene Symbol: MLST8
3 Cross references
198 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSKMAG00000018308
Gene Symbol: NQO1
1 Cross references
186 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSKMAG00000002785
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSKMAG00000011635
Gene Symbol: LOC108243046
3 Cross references
192 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSKMAG00000019970
Gene Symbol: LOC108240907
3 Cross references
180 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSKMAG00000000981
Gene Symbol: PIM3
3 Cross references
172 Possible Orthologues:

Rac-Beta Serine/threonine-Protein Kinase

Ensembl ID : ENSKMAG00000003604
Gene Symbol: LOC108238174
3 Cross references
210 Possible Orthologues:

Rac-Gamma Serine/threonine-Protein Kinase

Ensembl ID : ENSKMAG00000002799
Gene Symbol: LOC108244154
3 Cross references
203 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSKMAG00000013649
Gene Symbol: RAF1
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).